Calciphylaxis (Calcific Uremic Arteriolopathy)

[1]  C. Reutelingsperger,et al.  Vascular calcification in chronic kidney disease: an update. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  G. Frawley,et al.  Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review , 2015, Nephrology.

[3]  P. Parfrey,et al.  The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[4]  B. Astor,et al.  Pilot Study of the Effect of Lanthanum Carbonate (Fosrenol®) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study , 2014, Journal of nephrology & therapeutics.

[5]  S. Brunelli,et al.  Sodium thiosulfate therapy for calcific uremic arteriolopathy. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[6]  M. Hoang,et al.  Cutaneous Calciphylaxis: A Retrospective Histopathologic Evaluation , 2013, The American Journal of dermatopathology.

[7]  R. Weenig,et al.  Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. , 2012, Journal of the American Academy of Dermatology.

[8]  M. Wolf,et al.  Calciphylaxis from nonuremic causes: a systematic review. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[9]  R. Weenig.  Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. , 2008, Journal of the American Academy of Dermatology.

[10]  M. Pittelkow,et al.  Calciphylaxis: natural history, risk factor analysis, and outcome. , 2007, Journal of the American Academy of Dermatology.

[11]  C. Giachelli.  Vascular calcification mechanisms. , 2004, Journal of the American Society of Nephrology : JASN.

[12]  M. Pittelkow,et al.  Low-dose tissue plasminogen activator for calciphylaxis. , 2004, Archives of dermatology.

[13]  P. Monney,et al.  Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  D. Spector,et al.  Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  R. Lazova,et al.  Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis. , 2004, Journal of the American Academy of Dermatology.

[16]  D. Towler,et al.  Osteogenic regulation of vascular calcification: an early perspective. , 2004, American journal of physiology. Endocrinology and metabolism.

[17]  J. English,et al.  Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy , 2004, Journal of cutaneous pathology.

[18]  J. Arbiser,et al.  Weight Loss‐Induced Calciphylaxis: Potential Role of Matrix Metalloproteinases , 2003, The Journal of dermatology.

[19]  B. Don,et al.  A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. , 2003, Clinical nephrology.

[20]  E. Kurzrock,et al.  Penile calciphylaxis: analysis of risk factors and mortality. , 2003, The Journal of urology.

[21]  C. Basile,et al.  Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. , 2002, Journal of nephrology.

[22]  P. Price,et al.  The Amino Bisphosphonate Ibandronate Prevents Calciphylaxis in the Rat at Doses that Inhibit Bone Resorption , 2002, Calcified Tissue International.

[23]  C. Magro,et al.  Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment , 2002, Seminars in dialysis.

[24]  I. Mirza,et al.  An unusual presentation of calciphylaxis due to primary hyperparathyroidism. , 2009, Archives of pathology & laboratory medicine.

[25]  F. Cosio,et al.  Transcutaneous oxygen tension in patients with calciphylaxis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  D. Hirsch,et al.  Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  M. Wick,et al.  Cutaneous calciphylaxis. An underrecognized clinicopathologic entity. , 2000, American journal of clinical pathology.

[28]  H. Malluche,et al.  Calcific uremic arteriolopathy in association with low turnover uremic bone disease. , 1999, Clinical nephrology.

[29]  A. Pellegrini,et al.  Calciphylaxis associated with metastatic breast carcinoma. , 1999, Journal of the American Academy of Dermatology.

[30]  Y. Nishizawa,et al.  1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. , 1998, Circulation.

[31]  F. Llach.  Calcific uremic arteriolopathy (calciphylaxis): an evolving entity? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  J. Knochel,et al.  Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  Sewon Kang,et al.  Calciphylaxis without renal failure. , 1996, Archives of dermatology.

[34]  G. Burg,et al.  Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. , 1995, Journal of the American Academy of Dermatology.

[35]  C. Francis,et al.  Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. , 1990, The American journal of medicine.